These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 19195449)
21. Evolution of full-length HBV sequences in chronic hepatitis B patients with sequential lamivudine and adefovir dipivoxil resistance. Chen CH; Lee CM; Tung WC; Wang JH; Hung CH; Hu TH; Wang JC; Lu SN; Changchien CS J Hepatol; 2010 Apr; 52(4):478-85. PubMed ID: 20185198 [TBL] [Abstract][Full Text] [Related]
22. Hepatitis B virus escape mutants induced by antiviral therapy. Sheldon J; Soriano V J Antimicrob Chemother; 2008 Apr; 61(4):766-8. PubMed ID: 18218641 [TBL] [Abstract][Full Text] [Related]
23. Prevalence of viral hepatitis and molecular analysis of HBV among voluntary blood donors in west Iran. Doosti A; Amini-Bavil-Olyaee S; Tajbakhsh E; Adeli A; Mahboudi F New Microbiol; 2009 Apr; 32(2):193-8. PubMed ID: 19579699 [TBL] [Abstract][Full Text] [Related]
24. Substantial variation in the hepatitis B surface antigen (HBsAg) in hepatitis B virus (HBV)-positive patients from South Africa: Reliable detection of HBV by the Elecsys HBsAg II assay. Gencay M; Vermeulen M; Neofytos D; Westergaard G; Pabinger S; Kriegner A; Seffner A; Gohl P; Huebner K; Nauck M; Kaminski WE J Clin Virol; 2018 Apr; 101():38-43. PubMed ID: 29414186 [TBL] [Abstract][Full Text] [Related]
25. The detection of hepatitis viruses. Karayiannis P Methods Mol Biol; 2011; 665():79-100. PubMed ID: 21116797 [TBL] [Abstract][Full Text] [Related]
26. [Use of virus-induced damage markers in the diagnosis of viral hepatitis]. Randone A; Oliveri F; Piantino P; Colombatto P; Verme G; Bonino F; Brunetto MR Minerva Gastroenterol Dietol; 1995 Dec; 41(4):261-3. PubMed ID: 8664411 [No Abstract] [Full Text] [Related]
27. Comparative molecular biology of the hepatitis viruses. Miller RH Semin Liver Dis; 1991 May; 11(2):113-20. PubMed ID: 1653457 [No Abstract] [Full Text] [Related]
28. [Hepatitis B viral mutation and its clinical significance]. Asahina Y; Izumi N Nihon Rinsho; 2004 Aug; 62 Suppl 8():167-74. PubMed ID: 15453309 [No Abstract] [Full Text] [Related]
29. Human hepatitis B virus mutants: significance of molecular changes. Chen WN; Oon CJ FEBS Lett; 1999 Jun; 453(3):237-42. PubMed ID: 10405152 [TBL] [Abstract][Full Text] [Related]
30. Effects of interferon alpha therapy on the catalytic domains of the polymerase gene and basal core promoter, precore and core regions of hepatitis B virus. Chen RY; Bowden S; Desmond PV; Dean J; Locarnini SA J Gastroenterol Hepatol; 2003 Jun; 18(6):630-7. PubMed ID: 12753143 [TBL] [Abstract][Full Text] [Related]
31. Characterization of occult hepatitis B virus infection among HIV positive patients in Cameroon. Gachara G; Magoro T; Mavhandu L; Lum E; Kimbi HK; Ndip RN; Bessong PO AIDS Res Ther; 2017 Mar; 14(1):11. PubMed ID: 28270215 [TBL] [Abstract][Full Text] [Related]
32. [Pathogen spectrum in chronic viral hepatitis--HBV, HCV and new candidates]. Weissbrich B Krankenpfl J; 2002; 40(10-12):292-5. PubMed ID: 12600012 [No Abstract] [Full Text] [Related]
33. Analysis of HCV co-infection with occult hepatitis B virus in patients undergoing IFN therapy. Khattab E; Chemin I; Vuillermoz I; Vieux C; Mrani S; Guillaud O; Trepo C; Zoulim F J Clin Virol; 2005 Jun; 33(2):150-7. PubMed ID: 15911431 [TBL] [Abstract][Full Text] [Related]
34. Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela. Gutiérrez C; Devesa M; Loureiro CL; León G; Liprandi F; Pujol FH J Med Virol; 2004 Jun; 73(2):200-7. PubMed ID: 15122793 [TBL] [Abstract][Full Text] [Related]
35. Effect of schistosomiasis and hepatitis on liver disease. Halim AB; Garry RF; Dash S; Gerber MA Am J Trop Med Hyg; 1999 Jun; 60(6):915-20. PubMed ID: 10403320 [TBL] [Abstract][Full Text] [Related]
36. Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring. Manesis EK; Schina M; Le Gal F; Agelopoulou O; Papaioannou C; Kalligeros C; Arseniou V; Manolakopoulos S; Hadziyannis ES; Gault E; Koskinas J; Papatheodoridis G; Archimandritis AJ Antivir Ther; 2007; 12(3):381-8. PubMed ID: 17591028 [TBL] [Abstract][Full Text] [Related]
37. Molecular diagnostic techniques for viral hepatitis. Hu KQ; Vierling JM Gastroenterol Clin North Am; 1994 Sep; 23(3):479-98. PubMed ID: 7989090 [TBL] [Abstract][Full Text] [Related]
38. Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era. Maida I; Ríos MJ; Pérez-Saleme L; Ramos B; Soriano V; Pegram PS; Mura MS; Sánchez-Margalet V; Saldívar-Cornejo I; Wilkin A; Babudieri S; Núñez M AIDS Res Hum Retroviruses; 2008 May; 24(5):679-83. PubMed ID: 18462085 [TBL] [Abstract][Full Text] [Related]
39. Quantitative assessment of serum NV-F virus DNA concentrations in samples from patients coinfected with hepatitis B or C virus. Hsu CW; Cheng JC; Yeh CT J Clin Microbiol; 2006 Sep; 44(9):3130-3. PubMed ID: 16954237 [TBL] [Abstract][Full Text] [Related]
40. Genotypes and phylogenetic characterization of hepatitis B and delta viruses in Egypt. Saudy N; Sugauchi F; Tanaka Y; Suzuki S; Aal AA; Zaid MA; Agha S; Mizokami M J Med Virol; 2003 Aug; 70(4):529-36. PubMed ID: 12794714 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]